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) 
The Actinobacteria, Corynebacterium pseudotuberculosis strain P54B96, a nonmotile, non-
sporulating and a mesophile bacterium, was isolated from liver, lung and mediastinal lymph node 
lesions in an antelope from South Africa. This strain is interesting in the sense that it has been 
found together with non-tuberculous mycobacteria (NTMs) which could nevertheless play a role 
in the lesion formation. In this work, we describe a set of features of C. pseudotuberculosis 
P54B96, together with the details of the complete genome sequence and annotation. The genome 
comprises of 2.34 Mbp long, single circular genome with 2,084 protein-coding genes, 12 rRNA, 
49 tRNA and 62 pseudogenes and a G+C content of 52.19%. The analysis of the genome se-
quence provides means to better understanding the molecular and genetic basis of virulence of 
this bacterium, enabling a detailed investigation of its pathogenesis. 
Introduction Caseous lymphadenitis (CLA) or cheesy gland [1] is highly prevalent in many regions of the world, resulting in huge and significant economic losses in agribusiness since it is responsible for a de-crease in wool production and carcass quality [2]. Mainly small ruminant populations like sheep and goats, and other mammals, such as bovines, pigs, deer, ovines, equines, and even, though rarely, in 
camels and humans, are the victims of 
Corynebacterium pseudotuberculosis [3-6]. The disease is characterized by the presence of caseous necrosis in external and/or internal lymph nodes [1,7]. Ulcerative lymphangitis, which is confined to the lymph vessels of extremities particularly the hind legs, is a disease caused by this bacterium in the horse [8,9]. The bacterium in 
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some cases of human lymphadenitis, clinical strains are occasionally recovered [10]. The prevalence of CLA in the animals scattered throughout the globe needs effective measures to control the onset of the disease in herds along with the treatment of infected animals. Numerous reports have been published worldwide where mainly small ruminants are the carriers of the C. 
pseudotuberculosis. They include South Africa, Brazil, United States of America, Canada, Australia, New Zealand, United Kingdom and Egypt [11-18]. Histopathological examination of antelope car-casses from a South African game reserve, a part of their routine meat inspection, showed tubercu-losis-like lesions. These lesions were character-ized by the presence of encapsulated necrogranulomatous inflammation similar to CLA within the pulmonary tissues, in bronchial lymph nodes, liver, kidney and some other organs of the antelopes [11]. Diseases caused by the bacterium 
C. pseudotuberculosis are presented in various clinical forms as sheep and goats, affected with CLA [19]. Among the affected animal population, the increased prevalence and rapid transmission of the disease necessitates certain measures to control disease dissemination and prevent the nearby wildlife. The analysis of the genome se-quence will help us better understand the molecu-lar and genetic basis of virulence of this bacte-rium. 
Classification and Features 
C. pseudotuberculosis is a facultative intracellular pathogen showing pleomorphic forms like coccoids and filamentous rods, with sizes ranging between 0.5-0.6 µm and 1.0-3.0 µm [2]. Cells are described as Gram-positive, non-encapsulated, non-motile, non-sporulating and possessing fim-briae [12,20]. The bacterium was first isolated in 1888 from bovine farcy by Nocard and was first completely described by Preisz, showing its re-semblance to diphtheria bacillus. The organism has been previously named Bacillus pseudo-
tuberculosis ovis; Bacillus pseudo-tuberculosi and, 
Corynebacterium ovis [8,21]. It is a facultative an-aerobe. The best growth temperature and pH are 37o C and 7.0-7.2, respectively [17,22]. After ini-tially growing sparsely, strain P54B96 forms or-ganized clumps on the agar surface, demonstrat-ing dry opaque and concentrically ringed colo-nies. In liquid media it develops a granular de-posit with a surface pellicle [8,22,23]. 
There exist two biotypes of C. pseudo-
tuberculosis according to their capability of ni-trate reduction. Bacteria capable of performing the reduction of nitrate are classified into biovar 
equi (nitrate reduction positive; mainly isolated from horses and cattle) while the bacteria which can not perform the reduction of nitrate, pertain to biovar ovis (nitrate reduction negative; fre-quently isolated from sheep and goats) [2,24]. Corynebacteria possess an unusual structural organization in their cell envelope, similar to the Gram-negative bacteria [25] and belong to a very heterogeneous CMNR (Corynebacterium, 
Mycobacterium, Nocardia and Rhodococcus) group that shares characteristics including an outer lipid layer, mycolic acids in the cell wall along with with its derivatives including phos-pholipids and lipomannans [4]. Marchand et al. (2012) and others reported the presumed mycomembrane, an atypical outer membrane, pore-forming proteins like PorA and PorB, mycoloyltransferases, the so-called fibronectin-binding proteins like cMytA-D and cMytF, sever-al lipoproteins and some unknown putative C-terminal hydrophobic anchored proteins [26]. Analysis of amino acids and amino sugars of cell wall peptidoglycan reveals the presence of 
meso-diaminopimelic acid (meso-DAP). Major cell wall sugars are arabinose and galactose [17,27]. In addition, high and low molecular mass glucan, arabinomannan and lipoglycan al-so make part of the cell wall. Trehalose dimycolate (TDM) and trehalose monomycolate (TMM) are soluble cell envelope lipids [28]. Bio-chemically, all strains produce acid from glu-cose, maltose, fructose, sucrose and mannose [21,22]. This bacterium is catalase positive and phospholipase D, beta-hemolysis and oxidase negative [23,29]. 
Figure 1 shows the phylogenetic neighborhood of C. pseudotuberculosis strain P54B96 in an 
rpoB gene (β subunit of RNA polymerase) based tree. It has recently been shown that phyloge-netic analysis for the identification of 
Corynebacterium as well as other CMNR species based on rpoB gene sequences are more accu-rate than analyses based on 16S rRNA [42,43]. The rpoB gene sequences of reference strains from the CMNR group were used to construct the phylogenetic tree. 
Hassan et al. 
http://standardsingenomics.org 191 
Genome sequencing and annotation 
Genome project history This organism was selected for sequencing on the basis of its phylogenetic position. The genome project is deposited in the Genomes OnLine Data-base [44] and the complete genome sequence is available in GenBank (CP003385.1). Sequencing, finishing and annotation were performed by the Rede Paraense de Genômica e Proteômica (RPGP), Pará, Brazil. A summary of the project information is shown in Table 2.  
Growth conditions and DNA isolation 
C. pseudotuberculosis P54B96 was grown in brain-heart-infusion broth (BHI-HiMedia Laboratories Pvt. Ltda, India) in shake culture at140 rpm and at 37oC. Extraction of chromosomal DNA was performed by using 50 mL of 48–72 h culture of C. 
pseudotuberculosis, centrifuged at 4oC and 2000× g for 20 min. Re-suspension of cell pellets was done in 1 mL Tris/EDTA/NaCl [10 mM Tris/HCl (pH7.0), 10 mM EDTA (pH8.0), and 300 mM NaCl] for re-centrifugation under the same conditions. The pel-lets were re-suspended in 1 mL TE/lysozyme [25 mM Tris/HCl (pH8.0), 10 mM EDTA (pH8.0), 10 mM 
NaCl, and 10 mg lysozyme/mL]. The sample was then incubated at 37oC for 30 min and then 30 µL of 30% (w/v) sodium N- lauroyl-sarcosine (Sarcosyl) was added to it, incubated for 20 min at 65oC, fol-lowed by incubation for 5 min at 4oC. Purification of DNA with phenol/chloroform/isoamylalcohol (25:24:1) was followed by precipitation with etha-nol. DNA concentration was determined by spectro-photometer, and the DNA was visualized in ethidium bromide-stained 0.7% agarose gel. 
Genome sequencing and assembly The complete genome sequence of C. 
pseudotuberculosis P54B96 was obtained using the Ion Torrent PGM (Life Technologies) Sequenc-ing Platform. A total, of  562,812 reads were gen-erated, each with a mean size of 112 nts usable sequence (35-fold coverage). Furthermore, a hy-brid de novo assembly approach was applied us-ing 376,642 Ion filtered reads (19-fold coverage). This was carried out after quality filtering process during which reads representing an average Phred quality of less than 20, were removed. This strategy allowed closing gaps without bench work time cost [45]. 
 
Figure 1. Phylogenetic tree of C. pseudotuberculosis strain P54B96 representing its position relative to type strains in 
Corynebacteriaceae along with some other type strains of CMNR group. The tree was inferred from 3,537 aligned 
characters of the rpoB gene sequence using maximum likelihood method and then checked for its agreement with the 
current classification Table 1. The branch lengths represent the expected number of substitutions per site. Numbers ad-
jacent to the branches are support values from 1,000 bootstrap replicates, indicated when Larger than 60%. Calcula-
tions to determine the phylogenetic distances were done by the software MEGA v5 [30]. 
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Table 1. Classification and general features of C. pseudotuberculosis strain P54B96 according to the MIGS recommendations [31]. 
MIGS ID Property Term Evidence code 
 Classification Domain Bacteria TAS [32] 
  Phylum Actinobacteria TAS [33] 
  Class Actinobacteria TAS [34] 
  Order Actinomycetales TAS [34-37] 
  Suborder Corynebacterineae  
  Family Corynebacteriaceae TAS [34,35,37,38] 
  Genus Corynebacterium TAS [35,38,39] 
  Species Corynebacterium pseudotuberculosis TAS [35,40] 
  Strain P54B96 TAS [11] 
 Gram stain Positive TAS [21] 
 Cell shape pleomorphic forms TAS [21] 
 Motility non-motile TAS [8] 
 Sporulation non-sporulating TAS [22] 
 Temperature range mesophilic TAS [8,22] 
 Optimum temperature 37°C TAS [8,22] 
 Salinity not reported NAS 
MIGS-22 Oxygen requirement aerobic and facultatively anaerobic TAS [8,22] 
 Carbon source glucose, fructose, maltose, mannose, and sucrose TAS [8] 
 Energy source Chemoorganotroph TAS [8] 
MIGS-6 Habitat Host TAS [22] 
MIGS-15 Biotic relationship intracellular facultative pathogen TAS [22] 
MIGS-14 Pathogenicity sheep, goats, horses and cattle, rarely humans TAS [5,6] 
 Biosafety level 2 TAS [22] 
 Isolation liver, lung, mediastinal lymph node lesions of antelope TAS [11] 
MIGS-4 Geographic location Mpumalanga province, South Africa TAS [11] 
MIGS-5 Sample collection time 2009 TAS [11] 
MIGS-4.1 Latitude not reported  
MIGS-4.2 Longitude not reported  
MIGS-4.3 Depth not reported  
MIGS-4.4 Altitude not reported  
Evidence codes - IDA: Inferred from Direct Assay (first time in publication); TAS: Traceable Author Statement (i. e. a direct 
report exists in the literature); NAS: Non-traceable Author Statement (i. e. not directly observed for the living, isolated sam-
ple, but based on a generally accepted property for the species, or anecdotal evidence). These evidence codes are from 
the Gene Ontology project [41]. If the evidence code is IDA, then the property was directly observed for a living isolate by 
one of the authors or an expert mentioned in the acknowledgements. 
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Table 2. Genome sequencing project information 
MIGS ID Property Term 
MIGS-31 Finishing quality Finished 
MIGS-28 Libraries used Fragments (mean size 112 bp) 
MIGS-29 Sequencing platforms Semiconductor Ion Torrent PGM 
MIGS-31.2 Sequencing coverage 35-fold 
MIGS-30 Assemblers CLC Genome Workbench 4.7.2, Velvet 
MIGS-32 Gene calling method Glimmer v3.02 
 INSDC ID CP003385 (chromosome) 
 GenBank Date of Release April 05, 2012 
 GOLD ID Gc02176 
 NCBI project ID 77871 
 Database: IMG-GEBA 2512564058 
MIGS-13 Source material identifier BHI broth, P54B96 
 Project relevance Animal Pathogen, Medical  For homopolymer correction, an inherent prob-lem of the Ion Torrent [46], CLCBio Genome Workbench 4.7.2 was used. Having detected a high number of frameshifts, manual curation was required prior to analysis to prevent false-positive identification of pseudogenes. The ge-nome of P54B96 strain consists of 2,337,657 bp circular chromosome and the average G+C con-tent of the chromosome is 52.2%. The genome was predicted to contain 2,084 coding sequences (CDS), four rRNA operons, 49 tRNA and 62 pseudogenes. 
Genome annotation For automatic annotation, different programs were used. These include; Glimmer: gene predic-tor [47], RNAmmer: rRNA predictor [48]; tRNA-scan-SE: tRNA predictor [49]; and Tandem Repeat Finder: repetitive DNA predictor [50]. Functional annotation was performed by similarity analyses, using public databases of National Center for Bio-technology Information (NCBI) non-redundant database, Pfam and InterProScan software [51], which integrates multiple domain and protein family databases. Manual annotation was per-formed using Artemis [52]. 
Metabolic network analysis The metabolic Pathway/Genome Database (PGDB) was computationally generated using Pathway Tools software version 15.0 [53] and MetaCyc version 15.0 [54], based on annotated EC numbers and a customized enzyme name mapping file. There has been no manual curation in the data-base and it may contain errors, similar to a Tier 3 BioCyc PGDB [55]. 
Genome properties The genome is 2,337,657 bp long and comprises one main circular chromosome with a 52.19% GC content. A total of 2,207 genes were predicted, among which 2,146 were protein coding genes, and 61 RNAs; 62 pseudogenes were also identi-fied. Of the whole genome, 69.01% comprise genes that were assigned with putative functions, while the remaining genes were annotated as hy-pothetical proteins. The properties and statistics of the C. pseudotuberculosis genome are listed in Table 3. The distributions of genes into COGs func-tional categories is presented in Figure 2 and Ta-ble 4, followed by a cellular overview diagram in Figure 3 and a summary of metabolic network sta-tistics shown in Table 5. 
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Table 3. Genome Statistics 
Attribute Value % of Total 
Genome size (bp) 2,337,657 100.00% 
DNA coding region (bp) 2,005,391 85.79% 
DNA G+C content (bp) 1,219,912 52.19% 
Number of replicons 1  
Extrachromosomal elements 0  
Total genes 2,145 100.00% 
RNA genes 61 2.76% 
rRNA operons 4  
Protein-coding genes 2,084 97.16% 
Pseudo genes 62 2.81% 
Genes with function prediction 1,511 68.46% 
Genes in paralog clusters 425 19.26% 
Genes assigned to COGs 1,552 70.32% 
Genes assigned Pfam domains 1,596 72.32% 
Genes with signal peptides 651 29.50% 
Genes with transmembrane helices 584 26.46% 
CRISPR repeats 0  
 
Figure 2.Graphical circular map of the genome. From outside to the center: Genes on for-
ward strand (color by COG categories), Genes on reverse strand (color by COG catego-
ries), RNA genes (tRNAs green, rRNAs red, other RNAs black), GC content, GC skew. 
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Table 4. Number of genes associated with the general COG functional categories 
Code Value %age Description 
J 140 6.72 Translation, ribosomal structure and biogenesis 
A 1 0.1 RNA processing and modification 
K 121 5.8 Transcription 
L 88 4.2 Replication, recombination and repair 
B 0 0.0 Chromatin structure and dynamics 
D 21 1.0 Cell cycle control, cell division, chromosome partitioning 
Y 0 0.0 Nuclear structure 
V 25 1.2 Defense mechanisms 
T 54 2.6 Signal transduction mechanisms 
M 87 4.2 Cell wall/membrane biogenesis 
N 1 0.1 Cell motility 
Z 0 0.0 Cytoskeleton 
W 0 0.0 Extracellular structures 
U 27 1.3 Intracellular trafficking and secretion 
O 77 3.7 Posttranslational modification, protein turnover, chaperones 
C 90 4.3 Energy production and conversion 
G 113 5.4 Carbohydrate transport and metabolism 
E 177 8.5 Amino acid transport and metabolism 
F 73 3.5 Nucleotide transport and metabolism 
H 102 4.9 Coenzyme transport and metabolism 
I 57 2.7 Lipid transport and metabolism 
P 122 5.9 Inorganic ion transport and metabolism 
Q 26 1.3 Secondary metabolites biosynthesis, transport and catabolism 
R 169 8.1 General function prediction only 
S 136 6.5 Function unknown 
- 655 31.4 Not in COGs 
 
Figure 3. Schematic cellular overview of all pathways of the C. pseudotuberculosis P54B96 metabolism. 
Nodes represent metabolites, with shape indicating class of metabolite. Lines represent reactions. 
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Table 5. Metabolic Network Statistics 
Attribute Value 
Total genes 2,145 
Enzymes 500 
Enzymatic reactions 764 
Metabolic pathways 152 
Metabolites 622 
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